Insider Transactions Reported by 20 Insiders of HOOKIPA Pharma Inc.

Symbol
HOOK on OTC
Location
New York, NY

Insiders trading volume in the past year

HOOKIPA Pharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GILEAD SCIENCES, INC. 10%+ Owner $13,600,612 20 Dec 2023
Jorn Aldag Chief Executive Officer, Director $2,966,365 15 Apr 2024
Reinhard Kandera Chief Financial Officer, Director $1,249,842 15 Apr 2024
Roman Necina Chief Operations Officer $1,101,900 15 Apr 2024
Klaus Orlinger Chief Scientific Officer $1,101,900 15 Apr 2024
Christine D. Baker Chief Operating Officer $827,400 14 Apr 2023
Katia Schlienger Chief Medical Officer $552,943 14 Apr 2023
Igor Matushansky Chief Medical Officer $351,524 30 Jun 2022
Jan van de Winkel Director $156,000 17 Jun 2024
Mark Winderlich Chief Development Officer $150,000 15 Apr 2024
David Ross Kaufman Director $78,000 17 Jun 2024
Timothy P. Reilly Director $78,000 17 Jun 2024
Julie O'Neill Director $78,000 17 Jun 2024
Michael Aaron Kelly Director $60,000 30 Jun 2022
Mary Theresa Coelho EVP and CFO, Director $51,764 -$12,520 -19% 22 Jul 2025
Malte Peters Chief Executive Officer, Director $44,656 -$47,526 -52% 19 Aug 2025
Graziano Seghezzi Director $28,800 01 Jun 2021
Christoph Lengauer Director $28,800 01 Jun 2021
Jean-Charles Soria Director $28,800 01 Jun 2021
Sean A. Cassidy Director 22 Jul 2024

Recent Insider Transactions by Companies or Individuals for HOOKIPA Pharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.